Skip to main content

Advertisement

Table 1 First market approvals and current indications of ivermectin by country

From: 2018 in review: five hot topics in tropical medicine

Region First Approval Date Current Indications
Francea October 1987 Onchocerciasis, strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
United Statesb November 1996 Onchocerciasis, strongyloidiasis
Australiac June 1997 Onchocerciasis, strongyloidiasis, human sarcoptic scabies, crusted scabies
Japand October 2002 Strongyloidiasis, human sarcoptic scabies, crusted scabies
Netherlandse March 2003 Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
New Zealandf August 2005 Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
Germanya February 2016 Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
Canadag September 2018 Onchocerciasis, strongyloidiasis
  1. aEuropean Medicines Agency. Ivermectin (systemic use): List of nationally authorized medicinal products. Human Medicines Evaluation Division. Available at (accessed February 3, 2019): [https://www.ema.europa.eu/documents/psusa/ivermectin-systemic-use-list-nationally-authorised-medicinal-products-psusa/00002959/201502_en.pdf]
  2. bFood and Drug Administration. Labelling and Clinical Review of Final Printed Labelling: Stromectol (Ivermectin) 3 mg tablets (New Formulation). Center for Drug Evaluation and Research. 2000. Available at (accessed February 3, 2019): [https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/50-742s001_Stromectol_AdminCorres.PDF]
  3. cTherapeutic Goods Administration. AusPAR Product Information: Stromectol Tablets. 2013 Jul; Accessible at (accessed February 3, 2019): [https://www.tga.gov.au/sites/default/files/auspar-ivermectin-131030-pi.pdf]
  4. dPharmaceuticals and Medical Devices Agency. FY2006 List of Approved Products: New Drugs. 2006; Available at (accessed February 3, 2019): [https://www.pmda.go.jp/files/000153730.pdf]
  5. eMedicines Evaluation Board. Public Assessment Report – Scientific Discussion: Ivermectin Substipharm 3 mg tablets. 2018 Jul; Accessible at (accessed February 3, 2019): [https://db.cbg-meb.nl/Pars/h120488.pdf]
  6. fMedsafe. Medsafe Product Detail: Stromectol tablet 3 mg. 2018 Feb; Accessible at (accessed February 3, 2019): [https://www.medsafe.govt.nz/regulatory/ProductDetail.asp?ID=11299]
  7. gHealth Canada. Drug and health product submissions under review (SUR). Government of Canada. 2018. Available at (accessed February 3, 2019): [https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review.html]